Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating cancer using antibodies and molecules that immunospecifically bind to BTN1A1

Methods of treating cancer using antibodies and molecules that immunospecifically bind to BTN1A1

US Patent 12215151 · Granted Feb 4, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Composition and methods for MRNA vaccines against novel omicron coronavirus infe2025
Compositions and methods of mRNA vaccines against novel coronavirus infection2025
Methods for selecting antibodies that specifically bind glycosylated immune chec2024
Antibodies specific to glycosylated PD-1 and methods of use thereof2024
Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeu2024
Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeu2024
Antibodies specific to glycosylated PD-L1 and methods of use thereof2024
Methods of cancer treatment and therapy using a combination of antibodies that b2023
Dual function antibodies specific to glycosylated PD-L1 and methods of use there2023
Dual function antibodies specific to glycosylated PD-L1 and methods of use there2023
Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfata2023
Methods of treating cancer using antibodies and molecules that bind to BTN1A1 or2023